Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model
Giacomo Malipiero, Enrico Heffler, Corrado Pelaia, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Cutaneous manifestations in COVID‐19: a first perspective
Sebastiano Recalcati
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 5
Closed Access | Times Cited: 1349
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
Claudio Marasca, Maria Carmela Annunziata, Elisa Camela, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 48
Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2663-2672
Open Access | Times Cited: 56
The applications of eHealth technologies in the management of asthma and allergic diseases
Alberto Álvarez‐Perea, Ves Dimov, Florin‐Dan Popescu, et al.
Clinical and Translational Allergy (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 52
Allergic Diseases: A Comprehensive Review on Risk Factors, Immunological Mechanisms, Link with COVID-19, Potential Treatments, and Role of Allergen Bioinformatics
Fahad M. Aldakheel
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 22, pp. 12105-12105
Open Access | Times Cited: 47
Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper
Sylwia Smolińska, Florin‐Dan Popescu, Elena Izquierdo, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 777-792
Open Access | Times Cited: 10
Digital Allergology and Allergen-Immunotherapy in Germany
Ludger Klimek, Uso Walter, Sven Becker, et al.
Computers in health care (2025), pp. 329-339
Closed Access
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital
Giovanni Paoletti, Francesca Racca, Alessandra Piona, et al.
World Allergy Organization Journal (2021) Vol. 14, Iss. 5, pp. 100541-100541
Open Access | Times Cited: 23
The Role of Access and Cost-Effectiveness in Managing Asthma: A Systematic Review
Christopher D. Codispoti, Matthew Greenhawt, John Oppenheimer
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 2109-2116
Open Access | Times Cited: 15
mHealth and telemedicine utility in the monitoring of allergic diseases
Violeta Kvedarienė, Paulina Burzdikaitė, Inga Česnavičiūtė
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 12
The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation
Joseph A. Bellanti
Allergy and Asthma Proceedings (2020) Vol. 41, Iss. 6, pp. 397-412
Closed Access | Times Cited: 17
The Impact of COVID-19 Pandemic on Adult and Pediatric Allergy & Immunology Services in the UK National Health Service
Mamidipudi Thirumala Krishna, S. C. Beck, Nathan Gribbin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 9, Iss. 2, pp. 709-722.e2
Open Access | Times Cited: 17
Drug allergy management in the elderly
Jane C. Y. Wong, Philip H. Li
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 21, Iss. 4, pp. 340-345
Closed Access | Times Cited: 9
Digital health for allergen immunotherapy
Stephanie Dramburg, Paolo Maria Matricardi, Oliver Pfaar, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 293-298
Open Access | Times Cited: 5
Effect of patient and parental anxiety on adherence to subcutaneous allergen immunotherapy during the coronavirus disease 2019 pandemic
İlknur Külhaş Celík, Azize Pınar Metbulut, Özden Şükran Üneri, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 5, pp. 595-597
Open Access | Times Cited: 7
Paediatric allergy practice in the era of coronavirus disease 2019
S. Shahzad Mustafa, Marcus Shaker, Daniel Munblit, et al.
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 21, Iss. 2, pp. 159-165
Closed Access | Times Cited: 7
Telemedicine in the Management of Chronic Obstructive Respiratory Diseases: An Overview
Miguel T. Barbosa, Cláudia S. Sousa, Mário Morais‐Almeida
Digital Health (2022), pp. 131-144
Open Access | Times Cited: 5
Reply to correspondence to ‘Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus’
Jan Hagemann, Torsten Zuberbier, Giorgio Walter Canonica, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2574-2575
Open Access | Times Cited: 5
Prioritizing care for severe asthma during SARS-CoV-2 pandemic
Alida Benfante, Nicola Scichilone
Pulmonology (2020) Vol. 27, Iss. 3, pp. 189-190
Open Access | Times Cited: 4
Prognosis of COVID-19 in respiratory allergy: a systematic review and meta-analysis
Alia A. El Shahaway, Kelechi Elizabeth Oladimeji, Aboalmagd Hamdallah, et al.
Egyptian Journal of Bronchology (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 3
The effectiveness of telemedicine methods in the follow-up of asthma in the COVID-19 pandemic process
Şaban Melih Şimşek, Deniz Kızılırmak, Yavuz Havlucu
Tuberkuloz ve Toraks (2024) Vol. 72, Iss. 4, pp. 268-279
Open Access
Sublingual immunotherapy in the United States: history and current relevance in the time of COVID‐19
Sandra Y. Lin
International Forum of Allergy & Rhinology (2020) Vol. 10, Iss. 10, pp. 1125-1126
Open Access | Times Cited: 2
Asthma in the digital world
Jean Bousquet, Bernardo Sousa‐Pinto, Francesca Puggioni, et al.
Elsevier eBooks (2022), pp. 231-244
Closed Access | Times Cited: 1
Alerginių ligų gydymas COVID-19 laikotarpiu
Justina Šematonytė, Ieva Bajoriūnienė
Pulmonology and allergology (2020) Vol. 4, Iss. 2
Open Access
COVID-19 Pandemic—Allergen-specific Immunotherapy Positioning in Respiratory Allergy
Giorgio Walter Canonica
touchREVIEWS in Respiratory & Pulmonary Diseases (2020) Vol. 5, Iss. 1, pp. 10-10
Open Access
Page 1 - Next Page

Scroll to top